Acne scars got you down? Research suggests radiofrequency microneedling may help improve skin texture and reduce signs of aging, but more study is needed to confirm its benefits. Learn more about the latest findings on RFMN's effects on skin concerns.
SkinCareRadar tracks newly published skincare and dermatology research, then explains what the findings mean in plain language — with evidence labels, source links, and no hype.
Acne scars got you down? Research suggests radiofrequency microneedling may help improve skin texture and reduce signs of aging, but more study is needed to confirm its benefits. Learn more about the latest findings on RFMN's effects on skin concerns.
In VitroCell or tissue culture experiments. No human or animal data.Glycolic AcidPublished: April 28, 2026
Glycolic Acid-Integrated Nanocarriers May Help Treat Psoriasis
Researchers developed a new type of nanocarrier that combines glycolic acid, apremilast, and quercetin to treat psoriasis. In lab experiments, these nanocarriers showed promise in reducing inflammation and improving skin health. More studies are needed to confirm these findings.
Why it matters: This research may lead to new treatments for psoriasis, a chronic skin condition that affects millions of people worldwide.
This study was conducted in a lab setting and has not been tested in humans. Further research is needed to confirm the effectiveness and safety of these nanocarriers in real-world settings.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.AcnePublished: April 28, 2026
Radiofrequency Microneedling May Help Improve Skin Texture and Reduce Signs of Aging
Researchers studied the effectiveness of radiofrequency microneedling (RFMN) for various skin conditions, including acne scars, skin laxity, and rosacea. They found that RFMN may improve skin texture and reduce signs of aging, but the evidence is not consistent across all conditions. More research is needed to fully understand its benefits and limitations.
Why it matters: This study may help skincare professionals and individuals better understand the potential benefits and risks of RFMN for various skin concerns.
The study included a diverse range of studies, but the quality of the evidence varied, and the reporting of technical parameters was inconsistent. Additionally, the study did not compare RFMN to other treatments directly.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Lactic AcidPublished: April 27, 2026
PDLLA Injections May Cause Severe Granulomas in Lower Eyelid
Researchers studied a rare case of severe granulomas in a woman's lower eyelid after receiving PDLLA injections for infraorbital rejuvenation. The granulomas caused functional and aesthetic impairment, and conservative treatments failed. Surgical excision was required to manage the condition.
Why it matters: This case highlights the potential risks of PDLLA injections in the thin, anatomically complex lower eyelid region.
This case study involved a single patient, and the findings may not be representative of all individuals who receive PDLLA injections.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: April 27, 2026
Radiofrequency Microneedling's Impact on Surgical Facelifts Studied
Researchers studied how radiofrequency microneedling (RFMN) affects surgical facelifts. They found that RFMN may alter tissue planes and lead to complications like dermal scarring and tissue adhesions. However, the long-term effects of RFMN on facelifts are still uncertain.
Why it matters: Understanding RFMN's impact on surgical facelifts can help patients and healthcare providers make informed decisions about facial rejuvenation treatments.
This systematic review included 21 articles, but the long-term impact of RFMN on surgical facelifts remains uncertain. Further research is needed to determine optimal timing and treatment strategies.
In VitroCell or tissue culture experiments. No human or animal data.Lactic AcidAcnePublished: April 27, 2026
Postbiotic May Help Support Balanced Skin Microbiome
Researchers studied a postbiotic called PS-B1, made from fermented soy milk, to see how it affects beneficial skin bacteria. They found that a preservative-free version of PS-B1 may help some beneficial bacteria grow in lab experiments. However, more research is needed to confirm these findings.
Why it matters: Understanding how to support a balanced skin microbiome may be important for maintaining healthy skin.
This study was conducted in lab experiments and only looked at the effects of PS-B1 on a small number of skin bacteria strains. Further research is needed to confirm these findings and see if they apply to real-world skin health.
Animal StudyResults in animals only. May or may not translate to humans.HyperpigmentationPublished: April 27, 2026
Researchers studied a new skin treatment for UVB-induced pigmentation
A new skin treatment was studied for its ability to reduce pigmentation caused by UVB radiation. The treatment, made from a combination of tranexamic acid, metformin, and palmitoyl epigallocatechin gallate, was tested in lab experiments and found to enhance skin penetration and reduce melanin synthesis. The results suggest that this treatment may be effective in reducing UVB-induced skin pigmentation, but more research is needed to confirm these findings.
Why it matters: This study may help improve our understanding of how to treat UVB-induced skin pigmentation without invasive procedures.
This study was conducted in lab experiments and animal studies, and its results may not translate directly to human skin. Further research is needed to confirm the effectiveness and safety of this treatment in humans.
SkinCareRadar is a public research monitor focused on skincare ingredients, routines, devices, and skin conditions and concerns. It translates dermatology and cosmetic science research into plain language for the general public.
Every finding is linked to its original source. Evidence stages are labeled clearly. We do not diagnose, recommend treatment, or give medical advice. We distinguish cosmetic improvement from medically significant outcomes.